Tiludronate therapy for Paget's disease of bone
- 30 November 1995
- Vol. 17 (5) , S493-S496
- https://doi.org/10.1016/8756-3282(95)00282-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparative prospective, double‐blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of paget's disease of boneArthritis & Rheumatism, 1995
- Efficacy and tolerability of a new formulation of oral tiludronate (tablet) in the treatment of paget's disease of boneJournal of Bone and Mineral Research, 1994
- Oral tiludronate: Pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosisBone, 1992
- Evaluation of the efficacy and safety of oral tiludronate in paget's disease of boneArthritis & Rheumatism, 1992
- Treating Pagetʼs Disease of BoneThe Endocrinologist, 1992
- Treatment of Paget's disease of bone with (4-chloro-phenyl) thiomethylene bisphosphonateClinical Rheumatology, 1989
- Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of boneBone, 1988
- Long-Term Follow-up Observations on Treatment in Paget??s Disease of BonePublished by Wolters Kluwer Health ,1987
- Experimental Basis for the Use of Bisphosphonates in Paget??s Disease of BoneClinical Orthopaedics and Related Research, 1987
- MEASUREMENT OF PAINPublished by Elsevier ,1974